COPD Trial, Recruiting NCT06551441 Sponsor: Rigshospitalet, Denmark Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06551441
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 40 to 79 years (both men and women)
  • People who have been diagnosed with COPD at a mild to moderately severe level (known as GOLD stage I to III)
  • People with a breathlessness score ranging from none to quite severe on a standard scale (mMRC score of 0 to 3)
  • People whose blood oxygen level at rest is above 90%

Who may not be able to join:

  • People who have symptoms of reduced blood flow to the heart (such as chest pain or tightness during activity)
  • People with a known diagnosis of heart failure
  • People who are unable to complete or understand high-intensity interval training (HIIT) exercises
  • People who experience leg pain when walking due to poor circulation (known as claudication)
  • People who have had symptoms of illness in the two weeks before the study starts
  • People who have taken part in a lung rehabilitation program within the past three months
  • People with a known cancer diagnosis
  • People who are pregnant
  • People with an unstable heart rhythm condition
  • People with known chronic kidney or liver disease
  • People whose blood test results show abnormal levels of certain markers related to kidney or liver function (confirm with trial site for specific values)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 61698192

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 August 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Pulmonary blood volume (mL) at rest

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov